<?xml version="1.0" encoding="UTF-8"?>
<p>The fixed combination (Kan Jang) of 
 <italic>Andrographis</italic> and 
 <italic>Eleutherococcus</italic> has been used since 1979 in Sweden as an herbal medicine (“naturmedel”), with well‐established use (“naturläkemedel”) in Denmark since 1997 for reducing the severity and duration of symptoms of common cold.
 <xref rid="med21743-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref> This combination was tested in controlled clinical trials for the treatment of common cold and influenza‐associated uncomplicated upper respiratory infections as well as for the prevention of common colds.
 <xref rid="med21743-bib-0421" ref-type="ref">
  <sup>421</sup>
 </xref>, 
 <xref rid="med21743-bib-0422" ref-type="ref">
  <sup>422</sup>
 </xref>, 
 <xref rid="med21743-bib-0423" ref-type="ref">
  <sup>423</sup>
 </xref>, 
 <xref rid="med21743-bib-0424" ref-type="ref">
  <sup>424</sup>
 </xref> The studies confirmed the safety and superior efficacy of this combination regimen as compared with monodrug therapy,
 <xref rid="med21743-bib-0425" ref-type="ref">
  <sup>425</sup>
 </xref> presumably because of its antiviral effects,
 <xref rid="med21743-bib-0426" ref-type="ref">
  <sup>426</sup>
 </xref>, 
 <xref rid="med21743-bib-0427" ref-type="ref">
  <sup>427</sup>
 </xref>, 
 <xref rid="med21743-bib-0428" ref-type="ref">
  <sup>428</sup>
 </xref>, 
 <xref rid="med21743-bib-0429" ref-type="ref">
  <sup>429</sup>
 </xref>, 
 <xref rid="med21743-bib-0430" ref-type="ref">
  <sup>430</sup>
 </xref>, 
 <xref rid="med21743-bib-0431" ref-type="ref">
  <sup>431</sup>
 </xref>, 
 <xref rid="med21743-bib-0432" ref-type="ref">
  <sup>432</sup>
 </xref> effects on innate and adaptive immunity,
 <xref rid="med21743-bib-0433" ref-type="ref">
  <sup>433</sup>
 </xref>, 
 <xref rid="med21743-bib-0434" ref-type="ref">
  <sup>434</sup>
 </xref>, 
 <xref rid="med21743-bib-0435" ref-type="ref">
  <sup>435</sup>
 </xref>, 
 <xref rid="med21743-bib-0436" ref-type="ref">
  <sup>436</sup>
 </xref>, 
 <xref rid="med21743-bib-0437" ref-type="ref">
  <sup>437</sup>
 </xref> and anti‐inflammatory, antioxidant, and detoxifying effects
 <xref rid="med21743-bib-0438" ref-type="ref">
  <sup>438</sup>
 </xref>, 
 <xref rid="med21743-bib-0439" ref-type="ref">
  <sup>439</sup>
 </xref>, 
 <xref rid="med21743-bib-0440" ref-type="ref">
  <sup>440</sup>
 </xref>, 
 <xref rid="med21743-bib-0441" ref-type="ref">
  <sup>441</sup>
 </xref> of both adaptogenic plants as well as due to their synery.
 <xref rid="med21743-bib-0025" ref-type="ref">
  <sup>25</sup>
 </xref> It should be noted that the postmarketing pharmacovigilance assessment of Kan Jang showed a high benefit–risk ratio: one adverse event in about 100,000 patients was recorded for the 23‐year period from the adverse event reports (concerning mainly allergic reactions) to the Swedish and Danish medical product agencies. Further studies are needed to evaluate the efficacy of these plants in patients with COVID‐19 and other viral respiratory invidious diseases.
</p>
